Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
Clinical trial NCT01608594 · COMPLETED
Trial details
- NCT number
- NCT01608594
- Sponsor
- Diwakar Davar
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-21
- Primary completion
- 2017-02-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.